beta
IMNP
Immune Pharmaceuticals Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Immune Pharmaceuticals Inc, together with its subsidiaries, is a clinical stage biopharmaceutical company specializing in the development of novel targeted therapeutic agents in the fields of immuno-inflammation, dermatology and immuno-oncology.
Market Cap: 10.7 Million
Primary Exchange: NASDAQ Capital Market
Website: http://www.immunepharma.com
Shares Outstanding: 17.9 Million
Float: 9.76 Million
Dividend: 0.0 (0.0%)
Beta: 1.353054
Sector: Healthcare
Industry: Drug Manufacturers
Ethical Flags
Longest drawdown: 1170 trading days
From: 2014-03-20 To: 2018-07-26
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2017-04-13 | 20.0 | 1.0 | 20.0 |